lofexidine
Selected indexed studies
- Lofexidine. (, 2006) [PMID:30000984]
- Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review. (J Am Pharm Assoc (2003), 2020) [PMID:31791720]
- Lofexidine: A Newly FDA-Approved, Nonopioid Treatment for Opioid Withdrawal. (Ann Pharmacother, 2019) [PMID:30724094]
_Worker-drafted node — pending editorial review._
Connections
lofexidine is a side effect of
Sources
- New directions in the treatment of opioid withdrawal. (2020) pubmed
- Lofexidine. (2006) pubmed
- Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review. (2020) pubmed
- Lofexidine: A Newly FDA-Approved, Nonopioid Treatment for Opioid Withdrawal. (2019) pubmed
- Lofexidine: A Novel Treatment Option for Opioid Withdrawal Symptoms. (2020) pubmed
- Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. (2010) pubmed
- Lofexidine for opiate detoxification: review of recent randomised and open controlled trials. (1999) pubmed
- The Role of Lofexidine in Management of Opioid Withdrawal. (2019) pubmed
- Lofexidine and opioid withdrawal. (1995) pubmed
- Lofexidine for acute opioid withdrawal: A clinical case series. (2020) pubmed